Differential H2O2 Metabolism among Glioblastoma Subtypes Confers Variable Responses to Pharmacological Ascorbate Therapy Combined with Chemoradiation

My first first-author research article! While our clinical trial in GBM showed great promise with pharmacological ascorbate, patient responses were variable. Here, we present preliminary evidence showing that GBM subtypes metabolize H2O2 differently: h…